Proteomic analysis of plasma samples from acute coronary syndrome patients — The pilot study

Abstract

Molecular profiling technologies to assess the occurrence, appearance and amount of DNA, RNA, protein and metabolites provide the potential to the concept of “personalised medicine” [1]. Proteomic analysis, as one of the “omics” disciplines, is one of the most promising new methods for evaluating the translation of human genetic information into the “real time” synthesis of proteins and their posttranslational modifications from individual patient clinical conditions [2].